Regulated Cell Death (necroptosis, pyroptosis, ferroptosis, etc.) triggers inflammation, while excessive inflammatory responses further promote cell death and tissue damage, leading to various diseases such as inflammatory and autoimmune diseases. Intervention in the "Cell Death - Inflammation" loop has potential therapeutic effects on multiple diseases, with a broad market prospect.

Accropeutics focuses on the "Cell Death - Inflammation" loop and has established a unique "Regulated Cell Death" drug discovery platform. Accropeutics’ R&D team has broad experience from target validation to clinical development, and efficiently progressed a number of First in Class/Best in Class assets into clinical development.